MARKET

BIO-B

BIO-B

BIO RAD LABORATO
NYSE

Real-time Quotes | Nasdaq Last Sale

351.32
+0.66
+0.19%
Closed 16:00 03/31 EDT
OPEN
351.98
PREV CLOSE
332.00
HIGH
351.98
LOW
351.98
VOLUME
51
TURNOVER
--
52 WEEK HIGH
403.83
52 WEEK LOW
287.85
MARKET CAP
10.53B
P/E (TTM)
6.05
1D
5D
1M
3M
1Y
5Y

BIO-B News

More
  • Healthcare And Biotechnology Dashboard - Update
  • Seeking Alpha - Article · 03/24 18:33
  • Bio-Rad partners with laboratories for COVID-19 testing
  • Seeking Alpha - Article · 03/19 11:29
  • Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 02/14 02:04
  • IPO Update: Beam Therapeutics Proposes IPO Terms
  • Seeking Alpha - Article · 01/27 20:15

Industry

Medical Equipment, Supplies & Distribution
-0.22%
Healthcare Equipment & Supplies
-0.66%

Hot Stocks

Symbol
Price
%Change

About BIO-B

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.
More

Webull offers kinds of Bio-Rad Laboratories, Inc. stock information, including NYSE:BIO B real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO B stock news, and many more online research tools to help you make informed decisions.